Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

A Multicenter Open-Label Randomized Phase II Study of Osimertinib with and Without Ramucirumab in Tyrosine Kinase Inhibitor-Naïve EGFR-Mutant Metastatic Non-Small Cell Lung Cancer (RAMOSE Trial).

Xiuning Le,Jyoti D. Patel,Elaine Shum,Christina Baik,Rachel E. Sanborn,Catherine A. Shu,Chul Kim,Mary Jo Fidler,Richard Hall,Yasir Y. Elamin,Janet Tu,George Blumenschein,Jianjun Zhang,Don Gibbons,Carl Gay,Nisha A. Mohindra, Young Chae,Yanis Boumber,Joshua Sabari,Rafael Santana-Davila, Shane Rogosin,Benjamin Herzberg,Ben Creelan,Bruna Pellini,Tawee Tanvetyanon,Simon Heeke,Mike Hernandez,Jhanelle E. Gray,Andreas Saltos,John V. Heymach

JOURNAL OF CLINICAL ONCOLOGY（2025）

Cited 1|Views5
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined